Ryan N. Henderson

Array ( [id] => 6876797 [patent_doc_number] => 20010006950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'GENETIC VACCINE VECTOR ENGINEERING' [patent_app_type] => new-utility [patent_app_number] => 09/247888 [patent_app_country] => US [patent_app_date] => 1999-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 39976 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20010006950.pdf [firstpage_image] =>[orig_patent_app_number] => 09247888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4275052 [patent_doc_number] => 06245965 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Knockout mice and cells that lack p19INK4d and p27KIP1 activity and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 9/240906 [patent_app_country] => US [patent_app_date] => 1999-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 19 [patent_no_of_words] => 17675 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245965.pdf [firstpage_image] =>[orig_patent_app_number] => 240906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4375828 [patent_doc_number] => 06303334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Nucleic acid encoding a transdominant negative retroviral integrase' [patent_app_type] => 1 [patent_app_number] => 9/231182 [patent_app_country] => US [patent_app_date] => 1999-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7765 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303334.pdf [firstpage_image] =>[orig_patent_app_number] => 231182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6885501 [patent_doc_number] => 20010039666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-08 [patent_title] => 'NON-HUMAN MAMMALIAN MODEL FOR ATHEROSCLEROSIS AND METHODS FOR SCREENING AGENTS FOR USE IN THE TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => new [patent_app_number] => 09/229399 [patent_app_country] => US [patent_app_date] => 1999-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26509 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20010039666.pdf [firstpage_image] =>[orig_patent_app_number] => 09229399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6780178 [patent_doc_number] => 20030051260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'HMGI PROTEINS IN CANCER AND OBESITY' [patent_app_type] => new [patent_app_number] => 09/226402 [patent_app_country] => US [patent_app_date] => 1999-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23938 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20030051260.pdf [firstpage_image] =>[orig_patent_app_number] => 09226402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4422700 [patent_doc_number] => 06177610 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Major basic protein deficient animals' [patent_app_type] => 1 [patent_app_number] => 9/210017 [patent_app_country] => US [patent_app_date] => 1998-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4928 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177610.pdf [firstpage_image] =>[orig_patent_app_number] => 210017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1103791 [patent_doc_number] => 06811774 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-02 [patent_title] => 'Defective recombinant adenoviruses expressing cytokines for antitumor treatment' [patent_app_type] => B2 [patent_app_number] => 09/204427 [patent_app_country] => US [patent_app_date] => 1998-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3212 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/811/06811774.pdf [firstpage_image] =>[orig_patent_app_number] => 09204427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829199 [patent_doc_number] => 20030180257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'ALPHAVIRUS VECTORS FOR PARAMYXOVIRUS VACCINES' [patent_app_type] => new [patent_app_number] => 09/190246 [patent_app_country] => US [patent_app_date] => 1998-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7428 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180257.pdf [firstpage_image] =>[orig_patent_app_number] => 09190246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7013966 [patent_doc_number] => 20010051148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'COMPOSITIONS COMPRISING PRECONDITIONED MYOBLASTS HAVING ENHANCED FUSION PROPERTIES' [patent_app_type] => new [patent_app_number] => 09/188413 [patent_app_country] => US [patent_app_date] => 1998-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11007 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051148.pdf [firstpage_image] =>[orig_patent_app_number] => 09188413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6563807 [patent_doc_number] => 20020138864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'METHOD FOR TRANSFECTION OF AVIAN PRIMORDIAL GERM CELLS' [patent_app_type] => new [patent_app_number] => 09/183729 [patent_app_country] => US [patent_app_date] => 1998-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3033 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20020138864.pdf [firstpage_image] =>[orig_patent_app_number] => 09183729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550077 [patent_doc_number] => 06399383 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Human papilloma virus vectors' [patent_app_type] => B1 [patent_app_number] => 09/181072 [patent_app_country] => US [patent_app_date] => 1998-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 11491 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399383.pdf [firstpage_image] =>[orig_patent_app_number] => 09181072 [rel_patent_id] =>[rel_patent_doc_number] =>)